Resolute Onyx DES closeup on light blue background

Onyx ONE Clear Study

Evaluating Resolute Onyx™ DES in high bleeding risk patients with one month of DAPT, including subjects from the United States and Japan.

DON’T MISS OUT ON THIS IMPORTANT STUDY

Simply fill out the short form below to receive email updates as results become available.

* Indicates a required field.



ABOUT THIS DROPDOWN:
Select "Yes" to confirm you’d like to receive our Value in Healthcare emails. Selecting "No" will result in no emails from us, the same as not signing up, but is a required option under data privacy laws. We value your privacy, and you may discontinue receiving emails at any time using the unsubscribe link at the bottom of all Medtronic emails.

Your information will be collected and processed in accordance with our Privacy Statement.